Cmax i brevene var let forhøjet (23%) sammenlignet med kapslerne og opfyldte dermed ikke kriteriet for bioækvivalens.
Cmax of the sachet was slightly higher (23%) compared with the capsule and did not meet the criteria for bioequivalence.